Accueil / Tag Archives: Product/Service

Tag Archives: Product/Service

InDevR Launches Next-Generation Software for the Cypher One™ System

Tuesday, March 21st 2017 at 10:00am UTC Next Generation Cypher One™ Software Increases Functionality and Ensures Data Integrity for the Standardization of Hemagglutination and Hemagglutination Inhibition Assays BOULDER, Colo.–(BUSINESS WIRE)– InDevR, Inc., an innovative life science company dedicated to improving biopharmaceutical and vaccine manufacturing, today announced the global launch of …

Plus »

InVivo Therapeutics Announces Enrollment of New Patient into the INSPIRE Study at New Jersey’s Cooper Neurological Institute

Monday, March 20th 2017 at 12:00pm UTC CAMBRIDGE, Mass.–(BUSINESS WIRE)– InVivo Therapeutics Holdings Corp. (NVIV) today announced that a new patient has been enrolled into The INSPIRE Study (InVivo Study of Probable Benefit of the Neuro-Spinal Scaffold™ for Safety and Neurologic Recovery in Subjects with Complete Thoracic AIS A Spinal Cord …

Plus »

Chronix Biomedical Study Demonstrates Its Blood Test Can Predict Response to Cancer Immunotherapy

Monday, March 20th 2017 at 2:00pm UTC First study of a liquid biopsy to predict response to immunotherapy Highly accurate with a PPV of 92% and 100% for progression after one and two cycles respectively Early discovery of treatment-induced hyper-progressive disease Published in the peer-reviewed journal, Clinical Cancer Research SAN …

Plus »

Onxeo to Present Data Supporting Three Key Orphan Oncology Assets at AACR Annual Meeting

Tuesday, March 21st 2017 at 5:00pm UTC Preclinical studies of AsiDNATM, Livatag® and Beleodaq® PARIS–(BUSINESS WIRE)– class= »bwalignl »> Regulatory News: Onxeo S.A. (Paris:ONXEO) (NASDAQ OMX:ONXEO) (Euronext Paris, NASDAQ Copenhagen: ONXEO), a biotechnology company specializing in the development of innovative drugs for the treatment of orphan diseases, in particular in oncology, announced …

Plus »

Novaliq GmbH Announces Licensing Agreement with AFT Pharmaceuticals for the Distribution of NovaTears®

Monday, March 20th 2017 at 7:45pm UTC NovaTears®, A Novel Treatment for Dry Eye Disease, Is Now Available in Australia and New Zealand HEIDELBERG, Germany–(BUSINESS WIRE)– Novaliq, a specialty pharmaceutical company with a disruptive drug delivery platform that transforms poorly soluble drugs into effective therapeutics for ophthalmology, today announced a …

Plus »

ERYTECH présente de nouvelles données précliniques anti-tumorales avec erymethionase lors de l’AACR 2017

Monday, March 20th 2017 at 5:40pm UTC LYON, France–(BUSINESS WIRE)– Regulatory News: ERYTECH Pharma (Paris:ERYP) (ADR:EYRYY), société biopharmaceutique de stade clinique développant à partir de sa plateforme propriétaire d’encapsulation de médicaments dans les globules rouges des thérapies innovantes contre des formes rares de cancers et des maladies orphelines, annonce aujourd’hui …

Plus »

Ferring and CDI sign agreement granting Ferring exclusive marketing rights to VSL#3® in Europe and Canada

Monday, March 20th 2017 at 10:33am UTC SAINT-PREX, Switzerland–(BUSINESS WIRE)– Ferring Pharmaceuticals and CD Investments (CDI) announced today that they have signed an agreement granting Ferring exclusive European marketing rights to CDI’s VSL#3®. This agreement extends Ferring’s existing rights to market the product in the UK, Italy and Canada. VSL#3® …

Plus »

Poxel Announces Positive Results for Thorough QT Safety Clinical Study of Imeglimin

Tuesday, March 21st 2017 at 7:00am UTC LYON, France–(BUSINESS WIRE)– POXEL SA (Euronext – POXEL – FR0012432516), a biopharmaceutical company focused on the development of innovative treatments for type 2 diabetes, today announced that it has successfully completed a thorough QT/QTc (TQT) cardiac safety study on Imeglimin in 55 healthy …

Plus »

Thermo Fisher Scientific Showcases Newest Bioprocessing Technologies at INTERPHEX

Monday, March 20th 2017 at 12:00pm UTC Integrated products, software and services designed to increase customer innovation and productivity NEW YORK–(BUSINESS WIRE)– INTERPHEX 2017 – Thermo Fisher Scientific, the world leader in serving science, today announced it is featuring its latest bioprocessing technologies at the International Pharmaceutical Expo (INTERPHEX) at …

Plus »

Teewinot Life Sciences and Noramco Sign Letter of Intent to Produce Cannabinoids with Cannsynthesis™ Biocatalysis Technology

Monday, March 20th 2017 at 2:05pm UTC TAMPA, Fla. & WILMINGTON, Del.–(BUSINESS WIRE)– Teewinot Life Sciences (Teewinot), the market leader in biocatalytic technologies for the production of pharmaceutical-grade cannabinoids, and Noramco, a global leading producer of controlled-substance active pharmaceutical ingredients (APIs), today signed a letter of intent to enter the …

Plus »
Macbook Pro
* Intel Core i7 (3.8GHz, 6MB cache)
* Retina Display (2880 x 1880 px)
* NVIDIA GeForce GT 750M (Iris)
* 802.11ac Wi-Fi and Bluetooth 4.0
* Thunderbolt 2 (up to 20Gb/s)
* Faster All-Flash Storage (X1)
* Long Lasting Battery (9 hours)
BIENVENUE !
Vous appréciez cet article ? Faites-nous part de vos commentaires.
Recevez nos alertes, nos dernières actualités, suivez-nous, enregistrez-vous gratuitement, rejoignez notre communauté. Merci à vous !
ARE YOU READY? GET IT NOW!
Increase more than 500% of Email Subscribers!
Your Information will never be shared with any third party.
DÉCOUVREZ LA SOLUTION STRATA !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHA6Ly93d3cuZWVpLWJpb3RlY2hmaW5hbmNlcy5jb20vd3AtY29udGVudC91cGxvYWRzLzIwMTUvMDcvU2F0cmEtMi5tcDQiIGZyYW1lYm9yZGVyPSIwIiBhbGxvd2Z1bGxzY3JlZW4+PC9pZnJhbWU+
Retrouvez nous sur http://stratahealth.com/fr/
Un ensemble de solutions performantes
pour assurer le continuum de vos données.
SUIVEZ-NOUS, ENREGISTREZ-VOUS !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHA6Ly93d3cueW91dHViZS5jb20vZW1iZWQvajhsU2NITzJtTTAiIGZyYW1lYm9yZGVyPSIwIiBhbGxvd2Z1bGxzY3JlZW4+PC9pZnJhbWU+
All rights reserved © Company Name, 2014
Concours Genopole Young Biotech Award
* 100 000 € pour la meilleure Biotech
* Réservé aux biotechs hors santé
* 6 mois d'hébergement gratuit
* Un accompagnement personnalisé
* Etude de marché offerte
* Expertise du projet par EY
* Et nombre d'autres avantages...